Type 2 diabetes impairs pulmonary function in morbidly obese women: a case–control study
Tóm tắt
To determine whether the presence of type 2 diabetes and the degree of metabolic control are related to reduced pulmonary function in obese individuals. Seventy-five morbidly obese women (25 with type 2 diabetes [cases]—and 50 without diabetes [controls]) with a history of non-smoking and without prior cardiovascular or respiratory disease were prospective recruited for a case–control study in the outpatient obesity unit of a referral centre. Both groups were closely matched by age, BMI and waist circumference. Pulmonary function test included forced spirometry and static pulmonary volume measurements. Type 2 diabetic patients showed lower forced expiratory volume at 1 s (FEV1) (mean difference −11.6% of predicted [95% CI −20.4 to −2.8]; p = 0.011), and FEV1/forced vital capacity (FEV1/FVC) ratio (mean difference −4.4% [95% CI −8.1 to −0.7]; p = 0.049), but a greater residual volume (RV) (mean difference 19.5% of predicted [95% CI 10.8–28.3]; p < 0.001). In addition, an obstructive ventilatory pattern was more frequent in diabetic patients. Significant negative correlations between FEV1 and fasting glucose, HbA1c and HOMA insulin resistance (HOMA-IR) were detected. By contrast, RV was positively correlated with fasting glucose, HbA1c and HOMA-IR. Multiple linear regression analyses showed that fasting glucose and HbA1c independently predicted FEV1 and RV. The presence of diabetes and the degree of glycaemic control are related to respiratory function impairment in morbidly obese women. Therefore, the impact of type 2 diabetes on pulmonary function should be taken into consideration by those providing care for obese people.
Tài liệu tham khảo
World Health Organization (2006) Obesity and overweight. Fact Sheet No. 311. Available from www.who.int/mediacentre/factsheets/fs311/en/index.html, accessed 1 February 2009
Formiguera X, Canton A (2004) Obesity: epidemiology and clinical aspects. Best Pract Res Clin Gastroenterol 18:1125–1146
McClean KM, Kee F, Young IS, Elborn JS (2008) Obesity and the lung: epidemiology. Thorax 63:649–654
Steele RM, Finucane FM, Griffin SJ, Wareham NJ, Ekelund U (2009) Obesity is associated with altered lung function independently of physical activity and fitness. Obesity (Silver Spring) 17:578–584
Biring MS, Lewis MI, Liu JT et al (1999) Pulmonary physiologic changes of morbid obesity. Am J Med Sci 318:293–297
Chen Y, Rennie D, Cormier YF, Dosman J (2007) Waist circumference is associated with pulmonary function in normal-weight, overweight, and obese subjects. Am J Clin Nutr 85:35–39
Schünemann HJ, Dorn J, Grant BJ, Winkelstein W Jr, Trevisan M (2000) Pulmonary function is a long-term predictor of mortality in the general population: 29-year follow-up of the Buffalo Health Study. Chest 118:656–664
Barrett-Connor E, Frette C (1996) NIDDM, impaired glucose tolerance, and pulmonary function in older adults. The Rancho Bernardo Study. Diabetes Care 19:1441–1444
Davis TME, Knuiman M, Kendall P, Vu H, Davis WA (2000) Reduced pulmonary function and its associations in type 2 diabetes: the Fremantle Diabetes Study. Diabetes Res Clin Pract 50:153–159
Mannino DM, Thorn D, Swensen A, Holguin F (2008) Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. Eur Respir J 32:962–969
Yeh HC, Punjabi NM, Wang NY et al (2008) Cross-sectional and prospective study of lung function in adults with type 2 diabetes: the Atherosclerosis Risk in Communities (ARIC) Study. Diabetes Care 31:741–746
Davis WA, Knuiman M, Kendall P, Grange V, Davis TME (2004) Glycemic exposure is associated with reduced pulmonary function in type 2 diabetes. The Fremantle Diabetes Study. Diabetes Care 27:752–757
Sun Z, Liu L, Liu N, Liu Y (2008) Muscular response and adaptation to diabetes mellitus. Front Biosci 13:4765–4794
Lazarus R, Sparrow D, Weiss ST (1997) Handgrip strength and insulin levels: cross-sectional and prospective associations in the Normative Aging Study. Metabolism 46:1266–1269
Schnapf BM, Banks RA, Silverstein JH, Rosenbloom AL, Chesrown SE, Loughlin GM (1984) Pulmonary function in insulin-dependent diabetes mellitus with limited joint mobility. Am Rev Respir Dis 130:930–932
Ramirez LC, Dal Nogare A, Hsia C et al (1991) Relationship between diabetes control and pulmonary function in insulin dependent diabetes mellitus. Am J Med 91:371–376
Fernández-Real JM, Chico B, Shiratori M, Nara Y, Takahashi H, Ricart W (2008) Circulating surfactant protein A (SP-A), a marker of lung injury, is associated with insulin resistance. Diabetes Care 31:958–963
Sin DD, Man SF (2003) Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation 107:1514–1519
Nicolaie T, Zavoianu C, Nuta P (2003) Pulmonary involvement in diabetes mellitus. Rom J Intern Med 41:365–374
Lecube A, Sampol G, Lloberes P et al (2009) Diabetes is an independent risk factor for severe nocturnal hypoxemia in obese patients. A case–control study. PloS ONE 4:e4692
von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP, STROBE Initiative (2007) The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 370:1453–1457
Carey MA, Card JW, Voltz JW, Germolec DR, Korach KS, Zeldin DC (2007) The impact of sex and sex hormones on lung physiology and disease: lessons from animal studies. Am J Physiol Lung Cell Mol Physiol 293:272–278
Card JW, Zeldin DC (2009) Hormonal influences on lung function and response to environmental agents: lessons from animal models of respiratory disease. Proc Am Thorac Soc 6:588–595
McLaughlin T, Abbasi F, Cheal K, Chu J, Lamendola C, Reaven G (2003) Use of metabolic markers to identify overweight individuals who are insulin resistant. Ann Intern Med 139:802–809
Quanjer PH, Tammeling GJ, Cotes LE, Pedersen OF, Peslin R, Yernault JC (1993) Lung volumes and forced ventilatory flows. Report working party standardization of lung function tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J 16(suppl):5–40
Roca J, Sanchis J, Agusti-Vidal A et al (1986) Spirometric reference values from a Mediterranean population. Bull Eur Physiopathol Respir 22:217–224
Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS, GOLD Scientific Committee (2001) Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 163:1256–1276
Gold WM (2000) Pulmonary function testing. In: Murray JF, Nadel JA, Mason RJ, Boushey HA (eds) Textbook of respiratory medicine, 3rd edn. Elsevier Saunders, Philadelphia, pp 781–881
Fleming DM, Crombie DL, Cross KW (1991) Disease concurrence in diabetes mellitus: a study of concurrent morbidity over 12 months using diabetes mellitus as an example. J Epidemiol Community Health 45:73–77
Chance WW, Rhee C, Yilmaz C et al (2008) Diminished alveolar microvascular reserves in type 2 diabetes reflect systemic microangiopathy. Diabetes Care 31:1596–1601
Ahrén B (2004) GLP-1 and extra-islet effects. Horm Metab Res 36:842–845
Bullo M, García-Lorda P, Salas-Salvadó J (2002) Plasma soluble tumor necrosis factor alpha receptors and leptin levels in normal-weight and obese women: effect of adiposity and diabetes. Eur J Endocrinol 146:325–331
Murugan AT, Sharma G (2008) Obesity and respiratory diseases. Chron Respir Dis 5:233–242